Gastroesophageal Reflux Disease Therapeutics Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Gastroesophageal</strong><br />
<strong>Reflux</strong> <strong>Disease</strong><br />
<strong>Therapeutics</strong> <strong>Market</strong><br />
Share, Global Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation and Forecast,<br />
2016<br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and<br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports and country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.<br />
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for<br />
our client.<br />
Research Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Sector Coverage<br />
• Automotive and Transportation<br />
• Electronics, Semiconductor, and ICT<br />
• Retail and Consumer Products<br />
• Industrial Automation and Equipment<br />
• Chemicals & Materials<br />
• Food and Beverages<br />
• Services and Utilities<br />
• Energy, Mining, Oil, and Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com
Report Description<br />
<strong>Gastroesophageal</strong> reflux disease involves the backflow of stomach’s content to mouth<br />
through esophagus which gives a burning sensation behind breast bone.<br />
<strong>Gastroesophageal</strong> reflux disease is a common digestive disorder which affects the food<br />
pipe and lower esophageal sphincter by deteriorating its elasticity. <strong>Gastroesophageal</strong><br />
reflux disease occurs due to lifestyle changes and irregular eating habits & over<br />
consumption of fatty foods, coffee, alcoholic beverages, citrus fruits and pepper. In<br />
<strong>Gastroesophageal</strong> reflux disease there is excessive production of acid which damages the<br />
stomach lining and ultimately cause ulcers. <strong>Gastroesophageal</strong> reflux disease includes<br />
other symptoms such as regurgitation and dysphagia. However, abnormal reflux may<br />
cause uncharacteristic symptoms such as coughing, sore throat, otitis media, chest pain<br />
and enamel erosion or other dental manifestations.<br />
Continuous acid reflux disease can cause inflammation of esophagus called as<br />
esophagitis. <strong>Gastroesophageal</strong> reflux disease is a result of unevenness between the<br />
normal resistance mechanisms of the esophagus and aggressive components such as acid<br />
and other digestive juices and enzymes in the stomach.<strong>Gastroesophageal</strong> reflux disease<br />
can also be caused by the overdoing of certain medicines, such as calcium channel<br />
blockers, nitrates and antihistamines.<br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Disease</strong> <strong>Therapeutics</strong> <strong>Market</strong>: Drivers & Restraints<br />
<strong>Gastroesophageal</strong> reflux disease is a very common disease due to which the patient pool<br />
is very large.It affects all ages from infants to geriatric population. The prevalence of<br />
gastroesophageal reflux disease is increasing significantly across the globe. Increase in
Report Description<br />
The increase number of patients pursuing gastroesophageal reflux disease treatment and<br />
long term anti-reflux conservation therapy are expected to endure the gastroesophageal<br />
reflux diseasemarket during the forecast period.Gastro esophageal reflux disease market<br />
is also affected by the rapidly changing eating habits and changes in lifestyle. Although,<br />
everything is in favor but there are some unavoidable restraints such as patent expiry and<br />
weak drug pipeline which will pull back the market. The competition is very strong as<br />
there are many products available in the market for symptomatic treatment.<br />
Request Free Report Sample@<br />
http://www.futuremarketinsights.com/reports/sample/rep-gb-1410<br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Disease</strong> <strong>Therapeutics</strong> <strong>Market</strong>: Segmentation<br />
<strong>Gastroesophageal</strong> reflux disease market is classified on the basis of therapy, product and<br />
distribution channel.<br />
Based on product type, the global gastroesophageal reflux disease therapeutics market is<br />
segmented into following:<br />
Antacids<br />
Proton pump inhibitors<br />
H2 receptor blocker<br />
Pro kinetic agents
Report Description<br />
EndoCinch<br />
Stretta<br />
EsophyX<br />
Transoral Incisionless fundoplication<br />
Linx<br />
Based on distribution channel, the global gastro esophageal reflux disease therapeutics<br />
market is segmented into the following:<br />
Hospital pharmacy<br />
Drug stores<br />
General stores<br />
Supermarkets<br />
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1410<br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Disease</strong> <strong>Therapeutics</strong> <strong>Market</strong>: Overview<br />
<strong>Gastroesophageal</strong> reflux disease therapeutics market is predicted to decline during the<br />
forecast period due to the patent expiry of major producers. Innovations in terms of<br />
treatment modalities and commercialization of cost effective medicines are expected to<br />
boost gastroesophageal reflux disease therapeutics market during the forecast period.
Report Description<br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Disease</strong> <strong>Therapeutics</strong> <strong>Market</strong>: Region-wise Outlook<br />
Based on geographic regions, gastroesophageal reflux disease therapeutics market is<br />
segmented into seven key regions: North America, Latin America, Eastern Europe,<br />
Western Europe, Japan, Asia Pacific and Middle East & Africa. North America seized<br />
major share in the global market of gastroesophageal reflux disease therapeutics market<br />
due to increase in aging population and awareness of drug therapies followed by<br />
Western and Eastern Europe, Asia Pacific may have a negative impact on GERD in their<br />
daily lives due to which the acceptance rate of therapy is low and the prevalence in Asia<br />
pacific is low as well. The gastroesophageal reflux disease therapeutics market in japan<br />
will have a constant growth due to the balance between therapies and change in life<br />
style. Middle East and Africa holds promising future for rise in the global<br />
gastroesophageal reflux disease therapeutics market as expenditure on healthcare from<br />
foreign countries is increasing which is favouring the new drug development.<br />
Browse Full Report@ http://www.futuremarketinsights.com/reports/gastroesophagealreflux-disease-therapeutics-market<br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Disease</strong> <strong>Therapeutics</strong> <strong>Market</strong>: Key Players<br />
There are many key performers in gastroesophageal reflux disease therapeutics market<br />
some of the names who are leading the market in gastroesophageal reflux disease<br />
therapeutics market worldwide are AstraZeneca, Addex Pharmacetuicals, Vecam,<br />
Medigus, Peer Medical, EndoGastric Solutions, Eisai Co., Ltd, Takeda Pharmaceutical<br />
Company Limited, RaQualia Pharma Inc, Reviva Pharmaceuticals Inc, Rottapharm
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language